Cabaletta Bio, Inc. (CABA) Tops Q3 EPS by 3c

Cabaletta Bio, Inc. (NASDAQ: CABA) reported Q3 EPS of ($0.44), $0.03 better than the analyst estimate of ($0.47).

For earnings history and earnings-related data on Cabaletta Bio, Inc. (CABA) click here.

You May Also Be Interested In

• Matinas BioPharma to merge with GH Power, sell drug unit to Azurity
• AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
• XOVR ETF invests $30 million in Kalshi prediction market exchange